|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.85 USD | +1.02% |
|
-2.26% | +4.79% |
| Feb. 06 | Jefferies Adjusts Healthpeak Properties Price Target to $16 From $17, Maintains Hold Rating | MT |
| Feb. 06 | North American Morning Briefing : Futures Point to Gains After Thursday's Slide -2- | DJ |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.35 | 1.55 | 1.69 | 1.61 | 1.66 | |||||
Return on Total Capital | 1.54 | 1.75 | 1.9 | 1.79 | 1.83 | |||||
Return On Equity % | 1.9 | 7.12 | 4.71 | 3.34 | 1.16 | |||||
Return on Common Equity | 1.76 | 7.52 | 4.68 | 3.29 | 0.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 59.45 | 57.96 | 58.61 | 60.11 | 59.97 | |||||
SG&A Margin | 5.61 | 4.85 | 4.73 | 3.93 | 3.56 | |||||
EBITDA Margin % | 52.87 | 52.06 | 52.78 | 53.92 | 55.12 | |||||
EBITA Margin % | 22.27 | 22.53 | 22.95 | 24.82 | 26.88 | |||||
EBIT Margin % | 17.76 | 18.64 | 19.5 | 17.03 | 18.9 | |||||
Income From Continuing Operations Margin % | 7.26 | 24.91 | 15.35 | 9.9 | 3.58 | |||||
Net Income Margin % | 26.66 | 24.28 | 14.03 | 9 | 2.53 | |||||
Net Avail. For Common Margin % | 6.15 | 24.01 | 13.95 | 8.98 | 2.5 | |||||
Normalized Net Income Margin | 5.28 | 5.94 | 5.52 | 2.8 | 0.18 | |||||
Levered Free Cash Flow Margin | 143.66 | 46.27 | 43.75 | 28.53 | 41.19 | |||||
Unlevered Free Cash Flow Margin | 148.38 | 50.98 | 48.95 | 33.95 | 46.82 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.12 | 0.13 | 0.14 | 0.15 | 0.14 | |||||
Fixed Assets Turnover | 0.16 | 0.16 | 0.16 | 0.18 | 0.17 | |||||
Receivables Turnover (Average Receivables) | 15.28 | 21 | 29.87 | 5.35 | 4.98 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.35 | 1.39 | 1.8 | 1.15 | 1.22 | |||||
Quick Ratio | 0.78 | 0.29 | 0.6 | 0.48 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | 2.46 | 2.06 | 2.95 | 0.91 | 0.91 | |||||
Days Sales Outstanding (Average Receivables) | 23.88 | 17.38 | 12.22 | 68.44 | 73.29 | |||||
Average Days Payable Outstanding | 117.93 | 103.89 | 102.27 | 87.7 | 86.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 89.2 | 92.01 | 102.28 | 99.62 | 122.18 | |||||
Total Debt / Total Capital | 47.15 | 47.92 | 50.56 | 49.9 | 54.99 | |||||
LT Debt/Equity | 88.91 | 90.54 | 101.94 | 90.47 | 109.94 | |||||
Long-Term Debt / Total Capital | 46.99 | 47.15 | 50.39 | 45.32 | 49.48 | |||||
Total Liabilities / Total Assets | 53.16 | 53.79 | 55.89 | 54.57 | 59.17 | |||||
EBIT / Interest Expense | 2.13 | 2.22 | 2.12 | 1.64 | 1.75 | |||||
EBITDA / Interest Expense | 6.44 | 6.3 | 5.83 | 5.27 | 5.17 | |||||
(EBITDA - Capex) / Interest Expense | 6.44 | 6.3 | 5.83 | 5.27 | 5.17 | |||||
Total Debt / EBITDA | 6.27 | 6.15 | 6.06 | 6.1 | 6.42 | |||||
Net Debt / EBITDA | 6.11 | 6.09 | 5.94 | 6 | 6.12 | |||||
Total Debt / (EBITDA - Capex) | 6.27 | 6.15 | 6.06 | 6.1 | 6.42 | |||||
Net Debt / (EBITDA - Capex) | 6.11 | 6.09 | 5.94 | 6 | 6.12 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.28 | 8.7 | 5.81 | 23.82 | 4.52 | |||||
Gross Profit, 1 Yr. Growth % | 35.38 | 5.97 | 7 | 26.98 | 4.28 | |||||
EBITDA, 1 Yr. Growth % | 38.5 | 7.05 | 7.27 | 26.49 | 6.85 | |||||
EBITA, 1 Yr. Growth % | 64.23 | 9.98 | 7.77 | 33.88 | 13.2 | |||||
EBIT, 1 Yr. Growth % | 87.57 | 14.08 | 10.7 | 8.13 | 16.01 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -14.19 | 272.87 | -34.81 | -20.15 | -62.21 | |||||
Net Income, 1 Yr. Growth % | 22.24 | -1.01 | -38.85 | -20.54 | -70.66 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -19.86 | 324.52 | -39.44 | -35.54 | -72.11 | |||||
Normalized Net Income, 1 Yr. Growth % | -243.55 | 21.43 | 8.16 | -38.1 | -94.46 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.05 | 2.79 | 0.06 | 22.51 | 1.57 | |||||
Accounts Receivable, 1 Yr. Growth % | 7.38 | -42.79 | 4.46 | 13.39 | 8.8 | |||||
Total Assets, 1 Yr. Growth % | -4.16 | 3.37 | -0.46 | 27 | 1.99 | |||||
Common Equity, 1 Yr. Growth % | -3.24 | 2.14 | -4.57 | 32.29 | -10.73 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.51 | 4.02 | -3.22 | 24.88 | -9.83 | |||||
Cash From Operations, 1 Yr. Growth % | 4.85 | 13.2 | 6.22 | 11.95 | 16.95 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 72.8 | -64.95 | 0.06 | 19.6 | 40.44 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 65.24 | -62.61 | 1.58 | 21.03 | 35.65 | |||||
Dividend Per Share, 1 Yr. Growth % | -18.92 | 0 | 0 | 0 | 1.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 23.64 | 11.94 | 7.25 | 14.46 | 13.76 | |||||
Gross Profit, 2 Yr. CAGR % | 16.33 | 18.56 | 6.41 | 16.24 | 15.07 | |||||
EBITDA, 2 Yr. CAGR % | 16.72 | 20.34 | 7.07 | 16.08 | 16.25 | |||||
EBITA, 2 Yr. CAGR % | 10.56 | 30.1 | 8.65 | 19.16 | 23.11 | |||||
EBIT, 2 Yr. CAGR % | 5.09 | 39.72 | 12.1 | 8.35 | 12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -11.4 | 78.87 | 55.9 | -27.85 | -45.06 | |||||
Net Income, 2 Yr. CAGR % | 233.22 | 10 | -22.2 | -30.3 | -51.71 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -18.75 | 84.44 | 60.34 | -37.52 | -57.6 | |||||
Normalized Net Income, 2 Yr. CAGR % | 70.98 | 76.73 | 7.43 | -18.12 | -79.22 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 23.95 | 8.27 | 1.41 | 10.72 | 11.55 | |||||
Accounts Receivable, 2 Yr. CAGR % | -15.06 | -21.62 | -22.69 | 178.62 | 11.07 | |||||
Total Assets, 2 Yr. CAGR % | 4.27 | -0.47 | 1.44 | 12.44 | 13.81 | |||||
Common Equity, 2 Yr. CAGR % | 3.48 | -0.59 | -1.27 | 12.36 | 8.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.46 | 0.18 | 0.19 | 9.93 | 6.12 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.05 | 8.95 | 9.66 | 9.05 | 14.42 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.5 | -22.44 | -40.79 | -10.34 | 34.33 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 17.81 | -21.64 | -38.38 | -6.81 | 32.07 | |||||
Dividend Per Share, 2 Yr. CAGR % | -9.96 | -9.96 | 0 | 0 | 0.83 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 16.76 | 18.45 | 9.86 | 12.51 | 11.05 | |||||
Gross Profit, 3 Yr. CAGR % | 11.58 | 12.77 | 14.57 | 12.86 | 12.11 | |||||
EBITDA, 3 Yr. CAGR % | 11.9 | 13.4 | 15.82 | 13.19 | 12.92 | |||||
EBITA, 3 Yr. CAGR % | 6.38 | 10.37 | 22.19 | 16.48 | 17.14 | |||||
EBIT, 3 Yr. CAGR % | 2.57 | 8 | 29.29 | 10.76 | 10.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -45.21 | 43.04 | 27.76 | 24.74 | -41.84 | |||||
Net Income, 3 Yr. CAGR % | -21.9 | 122.34 | -9.55 | -21.65 | -47.76 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -50.16 | 40.99 | 27.24 | 18.34 | -52.25 | |||||
Normalized Net Income, 3 Yr. CAGR % | 75.34 | 52.88 | 45.38 | -10.14 | -64.15 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.11 | 16.45 | 5.46 | 8.01 | 7.58 | |||||
Accounts Receivable, 3 Yr. CAGR % | -50.33 | -25.54 | -13.74 | 64.38 | 103.65 | |||||
Total Assets, 3 Yr. CAGR % | 6.25 | 3.97 | -0.47 | 9.33 | 8.84 | |||||
Common Equity, 3 Yr. CAGR % | 3.1 | 3.03 | -1.93 | 8.84 | 4.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.06 | 2.3 | -1.06 | 7.82 | 2.91 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.15 | 2.09 | 8.03 | 10.41 | 11.62 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 39.49 | -23.76 | -15.56 | -34.34 | 6.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 34.58 | -19.67 | -14.56 | -31.17 | 7.77 | |||||
Dividend Per Share, 3 Yr. CAGR % | -6.75 | -6.75 | -6.75 | 0 | 0.55 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.29 | 2.2 | 12.86 | 16.84 | 11.4 | |||||
Gross Profit, 5 Yr. CAGR % | -3.98 | 3.01 | 9.51 | 14.27 | 14.77 | |||||
EBITDA, 5 Yr. CAGR % | -4.79 | 2.65 | 9.98 | 14.63 | 15.99 | |||||
EBITA, 5 Yr. CAGR % | -11.94 | -0.75 | 7.37 | 14.17 | 22.55 | |||||
EBIT, 5 Yr. CAGR % | -14.01 | -1.18 | 6.38 | 8.56 | 22.07 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -18.12 | 3.97 | -16.75 | 8.78 | -8.84 | |||||
Net Income, 5 Yr. CAGR % | -4.24 | 3.86 | -22.02 | 39.8 | -29.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -22.42 | 0.86 | -20.46 | 1.82 | -18.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | -8.56 | 16.84 | 45.33 | 17.18 | -33.23 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.64 | 4.32 | 5.38 | 14.12 | 7.86 | |||||
Accounts Receivable, 5 Yr. CAGR % | -34.88 | -41.12 | -40.71 | 26.23 | 39 | |||||
Total Assets, 5 Yr. CAGR % | -0.64 | 2.28 | 4.3 | 7.28 | 5.02 | |||||
Common Equity, 5 Yr. CAGR % | 3.27 | 4.65 | 1.33 | 6.66 | 2.18 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.42 | 4.98 | 1.31 | 5.23 | 1.75 | |||||
Cash From Operations, 5 Yr. CAGR % | -8.11 | 1.23 | 2.41 | 4.82 | 10.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -14 | -10.6 | -1 | -18.57 | -6.01 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -14.23 | -10.67 | -1.55 | -14.67 | -5.04 | |||||
Dividend Per Share, 5 Yr. CAGR % | -10.55 | -4.11 | -4.11 | -4.11 | -3.79 |
- Stock Market
- Equities
- DOC Stock
- Financials Healthpeak Properties, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















